Modulation of alternative splicing induced by paclitaxel in human lung cancer

Paclitaxel is utilized as the first-line chemotherapeutic regimen for the majority of advanced non-small-cell lung carcinoma. However, whether paclitaxel could suppress cancer progression through modulating RNA alternative splicing remains largely unknown. Here, we demonstrated the effects of paclit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Death Dis
Egile Nagusiak: Zhu, Ziran, Chen, Dan, Zhang, Wenjing, Zhao, Jinyao, Zhi, Lili, Huang, Fang, Ji, Haoyu, Zhang, Jinrui, Liu, Han, Zou, Lijuan, Wang, Yang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5924756/
https://ncbi.nlm.nih.gov/pubmed/29706628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0539-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak